# Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial

> **NCT00832754** · PHASE4 · COMPLETED · sponsor: **Kintampo Health Research Centre, Ghana** · enrollment: 3063 (actual)

## Conditions studied

- Malaria

## Interventions

- **DEVICE:** RDT
- **OTHER:** Clinical Judgement as basis for treatment of malaria with ACT

## Key facts

- **NCT ID:** NCT00832754
- **Lead sponsor:** Kintampo Health Research Centre, Ghana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 3063 (ACTUAL)
- **Last updated:** 2012-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832754, "Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00832754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*